<VariationArchive VariationID="916678" VariationName="IKBKG, 2-BP DEL, 1182TT" VariationType="Deletion" Accession="VCV000916678" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2020-06-13" MostRecentSubmission="2024-07-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="905011" VariationID="916678">
      <GeneList>
        <Gene Symbol="IKBKG" FullName="inhibitor of nuclear factor kappa B kinase regulatory subunit gamma" GeneID="8517" HGNC_ID="HGNC:5961" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154541238" stop="154565046" display_start="154541238" display_stop="154565046" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153770458" stop="153793260" display_start="153770458" display_stop="153793260" Strand="+" />
          </Location>
          <OMIM>300248</OMIM>
          <Haploinsufficiency last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>IKBKG, 2-BP DEL, 1182TT</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>2-BP DEL, 1182TT</Name>
      </OtherNameList>
      <XRefList>
        <XRef Type="Allelic variant" ID="300248.0027" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="IKBKG, 2-BP DEL, 1182TT AND ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED" Accession="RCV001172478" Version="3">
        <ClassifiedConditionList TraitSetID="53775">
          <ClassifiedCondition>ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2024-07-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="IKBKG, 2-BP DEL, 1182TT AND Incontinentia pigmenti syndrome" Accession="RCV001172479" Version="3">
        <ClassifiedConditionList TraitSetID="3124">
          <ClassifiedCondition DB="MedGen" ID="C0021171">Incontinentia pigmenti syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2024-07-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-07-18" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2020-06-13" MostRecentSubmission="2024-07-29">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20499091</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3124" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2304" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Incontinentia pigmenti, familial male-lethal type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bloch-Sulzberger syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Incontinentia pigmenti type 2 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IP2 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">INCONTINENTIA PIGMENTI, TYPE II</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Incontinentia pigmenti syndrome</ElementValue>
                <XRef ID="Incontinentia+pigmenti/3798" DB="Genetic Alliance" />
                <XRef ID="367520004" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IP</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IP2</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6778" />
                <XRef ID="6778" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Incontinentia pigmenti (IP) is a disorder that affects the skin, hair, teeth, nails, eyes, and central nervous system; it occurs primarily in females and on occasion in males. Characteristic skin lesions evolve through four stages: I. Blistering (birth to age ~4 months). II. Wart-like rash (for several months). III. Swirling macular hyperpigmentation (age ~6 months into adulthood). IV. Linear hypopigmentation. Alopecia, hypodontia, abnormal tooth shape, and dystrophic nails are observed. Neovascularization of the retina, present in some individuals, predisposes to retinal detachment. Neurologic findings including seizures, intellectual disability, and developmental delays are occasionally seen.</Attribute>
                <XRef ID="NBK1472" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301645</ID>
                <ID Source="BookShelf">NBK1472</ID>
              </Citation>
              <XRef ID="464" DB="Orphanet" />
              <XRef ID="C0021171" DB="MedGen" />
              <XRef ID="MONDO:0010631" DB="MONDO" />
              <XRef Type="MIM" ID="308300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="53775" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="53359" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED</ElementValue>
                <XRef Type="Allelic variant" ID="300248.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300248.0027" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300248.0028" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300248.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300248.0031" DB="OMIM" />
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2640609" SubmissionDate="2020-06-09" DateLastUpdated="2024-07-29" DateCreated="2020-06-13">
        <ClinVarSubmissionID localKey="300248.0027_INCONTINENTIA PIGMENTI" title="IKBKG, 2-BP DEL, 1182TT_INCONTINENTIA PIGMENTI" />
        <ClinVarAccession Accession="SCV001335509" DateUpdated="2024-07-29" DateCreated="2020-06-13" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-07-18">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 6-year-old boy with ectodermal dysplasia and immunodeficiency-1 (EDAID1; 300291), Roberts et al. (2010) identified a hemizygous 2-bp deletion (c.1182_1183delTT) in the IKBKG gene, predicted to result in a frameshift and premature termination affecting the zinc finger domain. The mutation was inherited from the patient's mother, who had features of incontinentia pigmenti (IP; 308300). Functional studies of the variant and studies of patient cells were not performed. The boy also had the additional features of osteopetrosis and edema, as well as some skin features of IP. Roberts et al. (2010) described the patient as having OLEDAID.</Attribute>
              <Citation>
                <ID Source="PubMed">20499091</ID>
              </Citation>
              <XRef DB="OMIM" ID="300291" Type="MIM" />
              <XRef DB="OMIM" ID="308300" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IKBKG" />
          </GeneList>
          <Name>IKBKG, 2-BP DEL, 1182TT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 1182TT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300248.0027" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">INCONTINENTIA PIGMENTI</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2640608" SubmissionDate="2020-06-09" DateLastUpdated="2024-07-29" DateCreated="2020-06-13">
        <ClinVarSubmissionID localKey="300248.0027_ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED" title="IKBKG, 2-BP DEL, 1182TT_ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED" />
        <ClinVarAccession Accession="SCV001335508" DateUpdated="2024-07-29" DateCreated="2020-06-13" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-07-18">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 6-year-old boy with ectodermal dysplasia and immunodeficiency-1 (EDAID1; 300291), Roberts et al. (2010) identified a hemizygous 2-bp deletion (c.1182_1183delTT) in the IKBKG gene, predicted to result in a frameshift and premature termination affecting the zinc finger domain. The mutation was inherited from the patient's mother, who had features of incontinentia pigmenti (IP; 308300). Functional studies of the variant and studies of patient cells were not performed. The boy also had the additional features of osteopetrosis and edema, as well as some skin features of IP. Roberts et al. (2010) described the patient as having OLEDAID.</Attribute>
              <Citation>
                <ID Source="PubMed">20499091</ID>
              </Citation>
              <XRef DB="OMIM" ID="300291" Type="MIM" />
              <XRef DB="OMIM" ID="308300" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IKBKG" />
          </GeneList>
          <Name>IKBKG, 2-BP DEL, 1182TT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 1182TT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300248.0027" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2640608" TraitType="Disease" MappingType="Name" MappingValue="ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED" MappingRef="Preferred">
        <MedGen CUI="C5394562" Name="ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1, MALE-RESTRICTED" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2640609" TraitType="Disease" MappingType="Name" MappingValue="INCONTINENTIA PIGMENTI" MappingRef="Alternate">
        <MedGen CUI="C0021171" Name="Incontinentia pigmenti syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

